Abstract

Hybrid nanostructures can be developed with inorganic nanoparticles (NPs) such as zinc oxide (ZnO) and natural antibacterials. ZnO NPs can also exert antibacterial effects, and we used them here to examine their dual action in combination with a natural antibacterial agent, protocatechuic acid (PCA). To produce hybrid nanoformulations, we functionalized ZnO NPs with four types of silane organic molecules and successfully linked them to PCA. Physicochemical assessment confirmed PCA content up to ~18% in hybrid nanoformulations, with a PCA entrapment efficiency of ~72%, indicating successful connection. We then investigated the in vitro release kinetics and antibacterial effects of the hybrid against Staphylococcus aureus. PCA release from hybrid nanoformulations varied with silane surface modification. Within 98 h, only 8% of the total encapsulated PCA was released, suggesting sustained long-term release. We used nanoformulation solutions collected at days 3, 5, and 7 by disc diffusion or log reduction to evaluate their antibacterial effect against S. aureus. The hybrid nanoformulation showed efficient antibacterial and bactericidal effects that also depended on the surface modification and at a lower minimum inhibition concentration compared with the separate components. A hybrid nanoformulation of the PCA prodrug and ZnO NPs offers effective sustained-release inhibition of S. aureus growth.

Highlights

  • As microorganisms exhibit an increasing and troubling resistance to drug therapies, including antibiotics, the search for new solutions has become urgent

  • Use of antibiotics as the main antibacterial agents against infection leads to significant adverse effects and antibiotic resistance [10], inspiring a search for new, safe alternatives

  • These results suggest that the significant antibacterial effect arises from the combination of released Zn2+ and protocatechuic acid (PCA), leaving no statistically significant difference between zinc oxide (ZnO), functionalized ZnO NPs, and nanoformulations

Read more

Summary

Introduction

As microorganisms exhibit an increasing and troubling resistance to drug therapies, including antibiotics, the search for new solutions has become urgent. Especially those that rely on alternative drug sources, including natural agents from plant-derived compounds [3]. These agents offer a cost-effective diversity of chemical structures that can serve as a basis for drug development. S. aureus is a common culprit in infections of the skin and soft tissue, urinary tract, and bloodstream and in infective endocarditis, osteomyelitis, pulmonary infections, gastroenteritis, and toxic shock syndrome [5,6] Incidence of these infections continues to grow, affecting medical care costs because of prolonged hospitalization [7].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call